BGM Group (BGM) vs Korro Bio (KRRO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Korro Bio (KRRO) has outperformed BGM Group (BGM) over the past year, losing 78.3% versus a loss of 96.3%. Over five years, KRRO leads with a -97.1% price change compared with -98.2% for BGM. Korro Bio is the larger company by market cap ($149.6 million vs $143.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGM | KRRO |
|---|---|---|
| Share price | $10.75 | $10.16 |
| Market cap | $143.56M | $149.61M |
| 1-day change | +10.94% | -3.97% |
| YTD return | -90.29% | +26.84% |
| 1-year return | -96.31% | -78.26% |
| 5-year return | -98.19% | -97.14% |
| EPS (TTM) | $-4.80 | $-9.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $303.00 | $55.89 |
| 52-week low | $6.45 | $5.20 |
| Distance from 52-week high | -96.45% | -81.82% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +98.82% |
| Average volume | 6.11K | 147.51K |
| Shares outstanding | 12.69M | 14.73M |
| Employees | — | 57 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KRRO has outperformed BGM by 18.1 percentage points over the past year.
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Health Care · Biotechnology: Pharmaceutical Preparations · 57 employees
BGM vs KRRO FAQ
Which is bigger, BGM Group or Korro Bio?
Korro Bio (KRRO) is larger, with a market capitalization of $149.61M compared with $143.56M for BGM Group (BGM).
Which stock has performed better over the past year, BGM or KRRO?
KRRO returned -78.26% over the past 12 months, compared with -96.31% for BGM (price return, excluding dividends). Past performance does not predict future results.
Are BGM Group and Korro Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.